Liver transplantation for HCV cirrhosis: Improved survival in recent years and increased severity of recurrent disease in female recipients: Results of a long term retrospective study

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Liver transplantation

• Publication date

  2007-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/lt.21093PMID 17370330
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Are we reporting the same thing?

  2007cited by this paper
• HLA-DRB1 donor-recipient mismatch affects the outcome of hepatitis C disease recurrence after liver transplantation.

  2006cited by this paper
• Significant improvement in the outcome of HCV-infected transplant recipients by avoiding rapid steroid tapering and potent induction immunosuppression.

  2006cited by this paper
• Insulin resistance is associated with steatosis in nondiabetic patients with genotype 1 chronic hepatitis C

  2006cited by this paper
• Fibrosis progression after liver transplantation in patients with recurrent hepatitis C.

  2004cited by this paper
• Impact of Donor Age and Year of Transplant on Graft Survival in Liver Transplant Recipients with Chronic Hepatitis C

  2004cited by this paper
• Report of the First International Liver Transplantation Society Expert Panel Consensus Conference on Liver Transplantation and Hepatitis C

  2003cited by this paper
• Liver Transplantation and Hepatitis C. Proceedings of a consensus development symposium.

  2003cited by this paper
• The role of immunosuppression in recurrence of hepatitis C

  2003cited by this paper
• The impact of advancing donor age on histologic recurrence of hepatitis C infection: The perils of ignored maternal advice

  2003cited by this paper
• Small‐for‐size syndrome: What is the problem?

  2003cited by this paper
• A model to predict severe HCV‐related disease following liver transplantation

  2003cited by this paper
• The association between hepatitis C infection and survival after orthotopic liver transplantation.

  2002cited by this paper
• Contribution of donor age to the recent decrease in patient survival among HCV‐infected liver transplant recipients

  2002cited by this paper
• HCV-related fibrosis progression following liver transplantation: increase in recent years.

  2000cited by this paper
• Early identification of recipients with progressive histologic recurrence of hepatitis C after liver transplantation

  2000cited by this paper
• Impact of immunosuppression and acute rejection on recurrence of hepatitis C: results of the National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database.

  1999cited by this paper
• European collaborative study on factors influencing outcome after liver transplantation for hepatitis C. European Concerted Action on Viral Hepatitis (EUROHEP) Group.

  1999cited by this paper
• Predictors of patient and graft survival following liver transplantation for hepatitis C

  1998cited by this paper
• Hepatitis C

  1998cited by this paper
• Cytomegalovirus viremia: risk factor for allograft cirrhosis after liver transplantation for hepatitis C.

  1997cited by this paper
• The natural history of portal hypertension after transjugular intrahepatic portosystemic shunts.

  1997cited by this paper
• Long-term outcome of hepatitis C infection after liver transplantation.

  1996cited by this paper
• Donor age and outcome of liver transplantation

  1996cited by this paper
• Severe or multiple rejection episodes are associated with early recurrence of hepatitis C after orthotopic liver transplantation

  1995cited by this paper
• Histological grading and staging of chronic hepatitis.

  1995cited by this paper
• Histological grading and staging of chronic hepatitis.

  1995cited by this paper

• Patient sex and use of tranexamic acid in liver transplantation

  2024cites this paper
• Causes of death and associated factors with death after liver transplantation: a nationwide database study.

  2023cites this paper
• Association between History of Pregnancy and Liver Fibrosis Using Fibrosis-4 Index in Korean Postmenopausal Women: A Nationwide Population-Based Study

  2022cites this paper
• Mortality and Causes of Death After Liver Transplantation: Analysis of Sex Differences in a Large Nationwide Cohort

  2022cites this paper
• Are Hepatitis C Positive Female Liver Transplant Recipients Still at Increased Risk for Graft Failure? Reexamining the Disparity in the Modern Era of Direct-acting Antiviral Agents

  2021cites this paper
• A systematic review for variables to be collected in a transplant database for improving risk prediction.

  2019cites this paper
• Inferior Outcomes Associated with the Coexistence of Hepatocellular Carcinoma Recurrence and Hepatic Virus Reinfection After Living Donor Liver Transplantation

  2019cites this paper
• Divergent impact of gender in advancement of liver injuries, diseases, and carcinogenesis.

  2018cites this paper
• Risk factors for early viral infections after liver transplantation

  2018cites this paper
• [Prophylaxis, diagnosis and therapy of hepatitis C virus (HCV) infection: the German guidelines on the management of HCV infection].

  2018cites this paper
• Severe Hepatitis C Recurrence as a Risk Factor for Opportunistic Infections in Liver Transplant Recipients.

  2018cites this paper
• Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis

  2018cites this paper
• Long‐term follow‐up of ribavirin‐free DAA‐based treatment in HCV recurrence after orthotopic liver transplantation

  2018cites this paper
• Liver transplantation for chronic hepatitis C virus infection in the United States 2002–2014: An analysis of the UNOS/OPTN registry

  2017cites this paper
• HCV Recurrence: Predictors and Outcomes After Liver Transplantation

  2016cites this paper
• Gender Mainstreaming and Transplant Surgery

  2016cites this paper
• Outcome of liver transplantation in patients with hereditary bleeding disorders: a single centre UK experience

  2016cites this paper
• [Treatment of hepatitis C before and after liver transplantation].

  2016cites this paper
• Tratamiento de la hepatitis C en el pre- y postrasplante hepático

  2016cites this paper
• Hepatitis C virus and liver transplantation: where do we stand?

  2016cites this paper
• Simeprevir or telaprevir with peginterferon and ribavirin for recurrent hepatitis C after living‐donor liver transplantation: A Japanese multicenter experience

  2016cites this paper
• Risk stratification of allograft failure secondary to hepatitis C recurrence after liver transplantation

  2016cites this paper
• Interferon-Free Therapy for Hepatitis C in Liver Transplant Recipients

  2016cites this paper
• ecipient female gender is a risk factor for graft loss after liver ransplantation for chronic hepatitis C : Evidence from the prospective iver Match cohort uca

  2015cites this paper
• Hepatitis C virus recurrence after liver transplantation: a 10-year evaluation.

  2015cites this paper
• Liver disease in menopause.

  2015cites this paper
• Survival of patients treated with sorafenib for hepatocellular carcinoma recurrence after liver transplantation: a systematic review and meta-analysis.

  2015cites this paper
• Recipient female gender is a risk factor for graft loss after liver transplantation for chronic hepatitis C: Evidence from the prospective Liver Match cohort.

  2015cites this paper
• Management of Hepatitis C Post-liver Transplantation: a Comprehensive Review

  2015cites this paper
• Chapter 11 – Transplantation for Hepatitis C

  2015cites this paper
• Consensus Interferon for Recurrent Hepatitis C Infection in Nonresponders to Peginterferon and Ribavirin After Liver Transplant.

  2015cites this paper
• Genderspezifische Unterschiede im Rahmen der Lebertransplantation

  2015cites this paper
• Interferon‐free antiviral treatment of chronic hepatitis C in the transplant setting

  2015cites this paper
• Female gender in the setting of liver transplantation.

  2014cites this paper
• Hepatitis C Recurrence after Orthotopic Liver Transplantation: Mechanisms and Management

  2014cites this paper
• Interferon-Free Regimens in the Liver-Transplant Setting

  2014cites this paper
• Impact of Anti-Thymocyte Globulin During Immunosuppression Induction in Patients with Hepatitis C After Liver Transplantation

  2014cites this paper
• Predictors of Disease Recurrence Post Living Donor Liver Transplantation in End Stage Chronic HCV Patients

  2014cites this paper
• Outcomes in liver transplantation: Does sex matter?

  2014cites this paper
• Post-liver transplant hepatitis C virus recurrence: an unresolved thorny problem.

  2014cites this paper
• A Prospective Policy Development to Increase Split-Liver Transplantation for 2 Adult Recipients: Results of a 12-Year Multicenter Collaborative Study

  2014cites this paper
• Recurrent HCV after liver transplantation—mechanisms, assessment and therapy

  2014cites this paper
• CXCL10 levels identify individuals with rapid fibrosis at 12 months post‐transplant for hepatitis C virus and predict treatment response

  2014cites this paper
• Excessive immunosuppression as a potential cause of poor survival in simultaneous liver/kidney transplantation for hepatitis C

  2014cites this paper
• Efficacy of new direct acting antivirals in transplant recipients and patients with advanced disease.

  2014cites this paper
• Donor‐specific alloantibodies are associated with fibrosis progression after liver transplantation in hepatitis C virus–infected patients

  2014cites this paper
• Treatment options in patients with decompensated cirrhosis, pre- and post-transplantation.

  2014cites this paper
• Improving long-term outcomes after liver transplantation.

  2014cites this paper
• Histopathological evaluation of recurrent hepatitis C after liver transplantation: a review.

  2014cites this paper
• Natural history, treatment and prevention of hepatitis C recurrence after liver transplantation: past, present and future.

  2014cites this paper
• Donor–Recipient Matching in HCV-Infected Patients

  2014cites this paper
• Natural History of Recurrent Hepatitis C: Impact of Immunosuppression

  2014cites this paper
• Long‐term Outcomes after Liver Transplantation

  2014cites this paper
• Early periportal sinusoidal fibrosis is an accurate marker of accelerated HCV recurrence after liver transplantation.

  2014cites this paper
• Recurrent hepatitis C after liver transplant.

  2014cites this paper
• Serum aspartate aminotransferase levels and previous histopathological findings enable reduction of protocol liver biopsies after liver transplantation for hepatitis C.

  2013cites this paper
• Recurrence of hepatitis C after liver transplantation

  2013cites this paper
• Progression of liver fibrosis in post-transplant hepatitis C: mechanisms, assessment and treatment.

  2013influential citation
• On the assessment and impact of liver fibrosis in patients with chronic hepatitis C

  2013influential citation
• The Hepatitis Aggressiveness Score (HAS): A Novel Classification System for Post–Liver Transplantation Recurrent Hepatitis C

  2013cites this paper
• How important is acute cellular rejection?

  2013cites this paper
• Management of recurrent hepatitis C in orthotopic liver transplant recipients.

  2013cites this paper
• Living-Donor Liver Transplantation and Hepatitis C

  2013cites this paper
• Tratamiento de la recurrencia de la infección por VHC en pacientes trasplantados hepáticos. Optimización del proceso

  2013cites this paper
• Influence of hepatitis C virus infection and high virus serum load on biliary complications in liver transplantation

  2013cites this paper
• Influence of Age and Gender Before and After Liver Transplantation

  2013cites this paper
• Hepatitis C infection and hepatocellular carcinoma in liver transplantation: a 20-year experience.

  2013cites this paper
• Rabbit anti‐thymocyte globulin in liver transplantation: All that glitters is not gold, but 1000 patients are so many to dazzle

  2012cites this paper
• Routine induction therapy in living donor liver transplantation prevents rejection but may promote recurrence of hepatitis C.

  2012cites this paper
• Treatment of hepatitis C recurrence is less successful in female than in male liver transplant recipients

  2012cites this paper
• Liver Transplantation and Hepatitis C

  2012cites this paper
• Recurrent hepatitis C after liver transplantation.

  2012cites this paper
• HCV in liver transplantation

  2012cites this paper
• Viral hepatitis in liver transplantation.

  2012cites this paper
• Spanish society of liver transplantation (SETH) consensus recommendations on hepatitis C virus and liver transplantation

  2012cites this paper
• HCV In At Risk Populations: Who Can be Treated and How?

  2012cites this paper
• Natural History of Chronic HCV After Liver Transplantation

  2012cites this paper
• Chapter 50 – Recurrent Viral Diseases after Liver Transplantation

  2012cites this paper
• Liver transplantation for HCV cirrhosis; cautious optimism after 10 years of experience.

  2012cites this paper
• Impact of donor histology on survival following liver transplantation for chronic hepatitis C virus infection: A Scandinavian single-center experience

  2012influential citation
• Outcome of induction immunosuppression for liver transplantation comparing anti‐thymocyte globulin, daclizumab, and corticosteroid

  2011cites this paper
• Hepatitis C virus–infected women have a higher risk of advanced fibrosis and graft loss after liver transplantation than men

  2011cites this paper
• Liver Transplantation for Hepatitis C: Disease Management

  2011cites this paper
• Explanted liver inflammatory grade predicts fibrosis progression in hepatitis C recurrence

  2011influential citation
• Recurrent Hepatitis C and Acute Allograft Rejection: Clinicopathologic Features With Emphasis on the Differential Diagnosis Between These Entities

  2011cites this paper
• Early activation of interferon-stimulated genes in human liver allografts: relationship with acute rejection and histological outcome

  2011cites this paper
• 36. Hepatic Transplantation

  2011cites this paper
• Management of recurrent hepatitis C infection after liver transplantation.

  2011cites this paper
• Hepatocellular carcinoma in unrelated viral cirrhosis: long-term results after liver transplantation.

  2010cites this paper
• Predictors of graft and patient survival in subjects undergoing transplantation for hepatitis C virus infection

  2010cites this paper
• Monitoring peripheral blood CD4+ Adenosine triphosphate activity in recurrent hepatitis C and its correlation to fibrosis progression

  2010cites this paper
• Treatment of recurrent hepatitis C post-liver transplantation.

  2010cites this paper
• Antibody‐Based Immunosuppression Following Liver Transplantation: The Plot Thickens

  2010influential citation
• Antiviral Treatment for Hepatitis C Virus Infection after Liver Transplantation

  2010cites this paper
• 42. Liver Transplantation: Prevention and Treatment of Rejection

  2010cites this paper
• Advances in hepatology: current developments in the treatment of hepatitis and hepatobiliary disease.

  2010cites this paper
• The immunosuppressive pipeline: Meeting unmet needs in liver transplantation

  2010cites this paper
• Liver Transplantation: Prevention and Treatment of Rejection

  2010cites this paper
• Hepatitis C recurrence is not adversely affected by the use of donation after cardiac death liver allografts

  2010cites this paper
• Hepatitis C

  2009cites this paper